- Home
- YOU vs AAPG Comparison
YOU vs AAPG Comparison
Compare YOU & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOU
- AAPG
- Stock Information
- Founded
- YOU 2010
- AAPG 2009
- Country
- YOU United States
- AAPG China
- Employees
- YOU N/A
- AAPG N/A
- Industry
- YOU Computer Software: Prepackaged Software
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- YOU Technology
- AAPG Health Care
- Exchange
- YOU Nasdaq
- AAPG Nasdaq
- Market Cap
- YOU 3.5B
- AAPG 3.6B
- IPO Year
- YOU 2021
- AAPG 2025
- Fundamental
- Price
- YOU $31.55
- AAPG $36.89
- Analyst Decision
- YOU Buy
- AAPG Buy
- Analyst Count
- YOU 6
- AAPG 1
- Target Price
- YOU $36.17
- AAPG N/A
- AVG Volume (30 Days)
- YOU 1.9M
- AAPG 7.4K
- Earning Date
- YOU 11-06-2025
- AAPG 11-06-2025
- Dividend Yield
- YOU 2.47%
- AAPG N/A
- EPS Growth
- YOU 105.20
- AAPG N/A
- EPS
- YOU 1.59
- AAPG N/A
- Revenue
- YOU $835,529,000.00
- AAPG $54,524,554.00
- Revenue This Year
- YOU $16.31
- AAPG N/A
- Revenue Next Year
- YOU $11.04
- AAPG $368.64
- P/E Ratio
- YOU $19.54
- AAPG N/A
- Revenue Growth
- YOU 19.85
- AAPG N/A
- 52 Week Low
- YOU $21.67
- AAPG $16.50
- 52 Week High
- YOU $39.00
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- YOU 40.68
- AAPG 44.32
- Support Level
- YOU $29.97
- AAPG $33.97
- Resistance Level
- YOU $31.20
- AAPG $40.23
- Average True Range (ATR)
- YOU 1.25
- AAPG 0.93
- MACD
- YOU -0.28
- AAPG -0.24
- Stochastic Oscillator
- YOU 27.91
- AAPG 44.89
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.